These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37827216)

  • 21. Aging-Related Mitochondrial Dysfunction Is Associated With Fibrosis in Benign Prostatic Hyperplasia.
    Adrian AE; Liu TT; Pascal LE; Bauer SR; DeFranco DB; Ricke WA
    J Gerontol A Biol Sci Med Sci; 2024 Jun; 79(6):. PubMed ID: 37738211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Androgen regulated genes in human prostate xenografts in mice: relation to BPH and prostate cancer.
    Love HD; Booton SE; Boone BE; Breyer JP; Koyama T; Revelo MP; Shappell SB; Smith JR; Hayward SW
    PLoS One; 2009 Dec; 4(12):e8384. PubMed ID: 20027305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Androgen receptor roles in the development of benign prostate hyperplasia.
    Izumi K; Mizokami A; Lin WJ; Lai KP; Chang C
    Am J Pathol; 2013 Jun; 182(6):1942-9. PubMed ID: 23570837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A rare castration-resistant progenitor cell population is highly enriched in Pten-null prostate tumours.
    Sackmann Sala L; Boutillon F; Menara G; De Goyon-Pélard A; Leprévost M; Codzamanian J; Lister N; Pencik J; Clark A; Cagnard N; Bole-Feysot C; Moriggl R; Risbridger GP; Taylor RA; Kenner L; Guidotti JE; Goffin V
    J Pathol; 2017 Sep; 243(1):51-64. PubMed ID: 28603917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epithelial-to-mesenchymal transition and estrogen receptor α mediated epithelial dedifferentiation mark the development of benign prostatic hyperplasia.
    Shao R; Shi J; Liu H; Shi X; Du X; Klocker H; Lee C; Zhu Y; Zhang J
    Prostate; 2014 Jun; 74(9):970-82. PubMed ID: 24752964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regional variations of insulin-like growth factor I (IGF-I), IGF-II, and receptor type I in benign prostatic hyperplasia tissue and their correlation with intraprostatic androgens.
    Monti S; Di Silverio F; Iraci R; Martini C; Lanzara S; Falasca P; Poggi M; Stigliano A; Sciarra F; Toscano V
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1700-6. PubMed ID: 11297606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Role of Heat Shock Protein 70 Subfamily in the Hyperplastic Prostate: From Molecular Mechanisms to Therapeutic Opportunities.
    Fu X; Liu H; Liu J; DiSanto ME; Zhang X
    Cells; 2022 Jun; 11(13):. PubMed ID: 35805135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Naftopidil enantiomers suppress androgen accumulation and induce cell apoptosis via the UDP-glucuronosyltransferase 2B15 in benign prostate hyperplasia.
    Zhan H; Zhang S; Li L; Chen Z; Cai Y; Huang J; Wu D; Huang B; Wu B; Liu X
    J Steroid Biochem Mol Biol; 2022 Jul; 221():106117. PubMed ID: 35504423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. STAT5a/b Deficiency Delays, but does not Prevent, Prolactin-Driven Prostate Tumorigenesis in Mice.
    Boutillon F; Pigat N; Sala LS; Reyes-Gomez E; Moriggl R; Guidotti JE; Goffin V
    Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31269779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NF-κB and androgen receptor variant expression correlate with human BPH progression.
    Austin DC; Strand DW; Love HL; Franco OE; Jang A; Grabowska MM; Miller NL; Hameed O; Clark PE; Fowke JH; Matusik RJ; Jin RJ; Hayward SW
    Prostate; 2016 Apr; 76(5):491-511. PubMed ID: 26709083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Local prolactin is a target to prevent expansion of basal/stem cells in prostate tumors.
    Rouet V; Bogorad RL; Kayser C; Kessal K; Genestie C; Bardier A; Grattan DR; Kelder B; Kopchick JJ; Kelly PA; Goffin V
    Proc Natl Acad Sci U S A; 2010 Aug; 107(34):15199-204. PubMed ID: 20699217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Promotion of epithelial hyperplasia by interleukin-8-CXCR axis in human prostate.
    Smith DK; Hasanali SL; Wang J; Kallifatidis G; Morera DS; Jordan AR; Terris MK; Klaassen Z; Bollag R; Lokeshwar VB; Lokeshwar BL
    Prostate; 2020 Sep; 80(12):938-949. PubMed ID: 32542667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined
    Pigat N; Reyes-Gomez E; Boutillon F; Palea S; Barry Delongchamps N; Koch E; Goffin V
    Front Pharmacol; 2019; 10():311. PubMed ID: 30984003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogen receptor-beta activated apoptosis in benign hyperplasia and cancer of the prostate is androgen independent and TNFalpha mediated.
    McPherson SJ; Hussain S; Balanathan P; Hedwards SL; Niranjan B; Grant M; Chandrasiri UP; Toivanen R; Wang Y; Taylor RA; Risbridger GP
    Proc Natl Acad Sci U S A; 2010 Feb; 107(7):3123-8. PubMed ID: 20133657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Correlation of prostate peripheral zone thickness with benign prostatic hyperplasia/ lower urinary tract symptoms: An update].
    Kong B; Hou X; Yang JY
    Zhonghua Nan Ke Xue; 2019 Aug; 25(8):744-748. PubMed ID: 32227720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transforming growth factor beta 1 and its receptor types I and II. Comparison in human normal prostate, benign prostatic hyperplasia, and prostatic carcinoma.
    Royuela M; De Miguel MP; Bethencourt FR; Sanchez-Chapado M; Fraile B; Paniagua R
    Growth Factors; 1998; 16(2):101-10. PubMed ID: 9932228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-Proliferative Effects of Standardized
    Jin BR; Cheon SY; Kim HJ; Kim MS; Lee KH; An HJ
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33334082
    [No Abstract]   [Full Text] [Related]  

  • 38. Progressive prostate hyperplasia in adult prolactin transgenic mice is not dependent on elevated serum androgen levels.
    Kindblom J; Dillner K; Ling C; Törnell J; Wennbo H
    Prostate; 2002 Sep; 53(1):24-33. PubMed ID: 12210477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination of Ligustri Lucidi Fructus with Ecliptae Herba and their phytoestrogen or phytoandrogen like active pharmaceutical ingredients alleviate oestrogen/testosterone-induced benign prostatic hyperplasia through regulating steroid 5-α-reductase.
    Tao R; Liu E; Zhao X; Han L; Yu B; Mao H; Yang W; Gao X
    Phytomedicine; 2022 Jul; 102():154169. PubMed ID: 35636178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age-dependent expression of the androgen receptor gene in the prostate and its implication in glandular differentiation and hyperplasia.
    Prins GS; Jung MH; Vellanoweth RL; Chatterjee B; Roy AK
    Dev Genet; 1996; 18(2):99-106. PubMed ID: 8934871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.